David J. Giarracco
Chief Executive Officer
Dave joined Noninvasix in 2021 to make a difference in sepsis care by commercializing a noninvasive technology with the potential to detect sepsis sooner and safer while personalizing patient management. He is a commercial leader driving business growth and value, guiding organizations in launching revolutionary technologies into existing markets, leading acquisition/integration efforts, developing new markets, and improving organizational efficiency. He has successfully scaled organizations to exceed strategic plans by addressing commercial structure creating clinically focused solution selling organizations.
Graham Randall, Ph.D., MBA
Chief Science Officer
Graham joined Noninvasix in 2013 and led the organization through its development of neonatal cerebral venous and adult central venous oximeter prototypes. Graham has founded three companies and launched medical devices, commercial software, and production websites. He has raised over $15M in funding and has been the principal investigator on three NIH grants. He began his career at AirTouch Cellular, Borland, and Tellme Networks, where he, respectively, led the software launch of the world’s first digital cellular network and developed the first voice recognition phone systems for stock trading and driving directions.
Donald Prough, M.D.
Clinical Vice President
Over 30 years experience in anesthesiology and critical care development and over 20 years experience in development and critical testing of systems for noninvasive monitoring. Dr. Prough is currently Rebecca Terry White Distinguished Chair and Professor of Anesthesiology and the Assistant Clinical Director of the Center for Biomedical Engineering at UTMB.